Globus Medical, Inc. P/E Ratio 2010–2025
Globus Medical, Inc. reported 22.27 of price-to-earnings ratio for fiscal 2025. That was 79.8% lower than fiscal 2024. Compared with fiscal 2020, the change was -65.5%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 22.27 | -79.8% |
| FY 2024 | 110.28 | +121.4% |
| FY 2023 | 49.80 | +24.1% |
| FY 2022 | 40.15 | -19.9% |
| FY 2021 | 50.14 | -22.4% |
| FY 2020 | 64.57 | +66.7% |
| FY 2019 | 38.74 | +37.8% |
| FY 2018 | 28.10 | -24.8% |
| FY 2017 | 37.36 | +62.6% |
| FY 2016 | 22.97 | -3.4% |
| FY 2015 | 23.78 | -3.0% |
| FY 2014 | 24.51 | -11.4% |
| FY 2013 | 27.64 | +110.8% |
| FY 2012 | 13.11 | — |
| FY 2011 | — | — |
| FY 2010 | — | — |
Source: Globus Medical, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open GMED 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Globus Medical, Inc. reported 22.27 of price-to-earnings ratio for fiscal 2025. That was 79.8% lower than fiscal 2024. Compared with fiscal 2020, the change was -65.5%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Globus Medical, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeGlobus Medical, Inc. — frequently asked questions
What is Globus Medical, Inc.'s price-to-earnings ratio?
Globus Medical, Inc. (GMED) reported price-to-earnings ratio of 22.27 for fiscal year 2025, per its SEC filings.
How has Globus Medical, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2010 and 2025, GMED's price-to-earnings ratio grew at roughly 3.6% per year (compound annual rate), from 13.11 to 22.27.
Where does this data come from?
Figures are computed from Globus Medical, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More GMED financial history
Full GMED fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →